LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 3.210
- +0.020+0.63%
Close Dec 27 16:00 ET
- 3.210
- 0.0000.00%
Post 20:01 ET
608.27MMarket Cap-7.47P/E (TTM)
3.220High3.115Low831.17KVolume3.160Open3.190Pre Close2.64MTurnover0.61%Turnover RatioLossP/E (Static)189.49MShares4.72552wk High5.69P/B437.26MFloat Cap2.21052wk Low--Dividend TTM136.22MShs Float31.480Historical High--Div YieldTTM3.29%Amplitude0.821Historical Low3.176Avg Price1Lot Size
About Arbutus Biopharma Company
Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
Company Profile
SymbolABUS
Company NameArbutus Biopharma
Listing DateJul 20, 2007
Founded2005
CEOMr. Michael J. McElhaugh
MarketNASDAQ
Employees73
Fiscal Year Ends12-31
Address701 Veterans Circle
CityWarminster
ProvincePennsylvania
CountryUnited States of America
Zip Code18974
Phone1-267-469-0914
Websitehttp://www.arbutusbio.com
Company Executives
- Name
- Position
- Salary
- Michael J. McElhaugh
- Director, Chief Executive Officer and Interim President
- 1.62M
- Karen Sims
- Chief Medical Officer
- --
- J. Christopher Naftzger
- General Counsel, Chief Compliance Officer and Secretary
- --
- Dr. Michael J. Sofia,PhD
- Chief Scientific Officer
- 1.61M
- David C. Hastings
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Frank M. Torti, M.D.
- Chairman of the Board
- 187.99K
- Richard C. Henriques, M.B.A.
- Independent Director
- 174.24K
- James R. Meyers
- Independent Director
- 176.74K
- Daniel D. Burgess
- Independent Director
- 161.74K
- Keith Manchester, M.D.
- Independent Director
- 156.74K
- Dr. Melissa V. Rewolinski, PhD
- Independent Director
- 212.09K